A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts. [electronic resource]
Producer: 19890525Description: 3004-7 p. digitalISSN:- 0041-1345
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Bone Marrow Transplantation -- immunology
- Drug Evaluation
- Graft vs Host Disease -- immunology
- Histocompatibility Testing
- Humans
- Immunotoxins -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- immunology
- Lymphocyte Depletion
- Male
- Postoperative Complications -- prevention & control
- Ricin -- immunology
- T-Lymphocytes
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.